Cannabis users experienced 14% more pain in the first 24 hours following surgery than non-cannabis users. Additionally, cannabis users consumed 7% more opioids post surgery.
Cannabis products and synthetic, medical cannabis can help to relieve neuropathic pain, a new study reports.
Cannabis users are less aware of unhealthy behaviors they exhibit, including using demands, criticisms, and being avoidant, when in a relationship conflict.
Cannabis users undergoing gastric endoscopy procedures generally require more sedation than non-cannabis users, researchers report.
Researchers identify problem areas they face in studying the effects of cannabis on the brain and heart function.
Legalized marijuana for recreational use reduces the demand for prescription medications, a new study reveals. Researchers found the volume of medical prescriptions for pain, sleep disorders, anxiety, and some neurological conditions declined significantly when recreational marijuana was legalized.
Cannabis terpenes, the part of the plant which provides aroma and flavor, may provide therapeutic benefits in controlling pain, a new study reports.
A new study in Zebrafish reveals exposure to compounds found in cannabis during the early stages of development was linked to a significant drop in neural activity later in life.
A new case study reveals medical marijuana may provide rapid relief for sufferers of chronic itch. Researchers say THC attaches itself to brain receptors that influence the nervous system. This reduces inflammation and nervous system activity, leading to a reduction in itch sensation.
While cannabis users reported more psychotic experiences than non-users generally, the effect was more pronounced in those with a genetic risk factor for schizophrenia.
Smoking marijuana affects several key visual functions, including 3D vision and contrast sensitivity. However, 90% of cannabis users believe the drug has either no, or minimal, effect on their visual abilities.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.
